The Barbra Streisand Women’s Heart Center in Cedars-Sinai’s Heart Institute will be named for the famed entertainer in recognition of her philanthropic commitment and it will be directed by C. Noel Bairey Merz, MD, a cardiologist and nationally respected expert on women’s cardiovascular disease.
Cedars-Sinai researchers say their examination of the fungi in the intestines suggests an important link between these microbes and inflammatory diseases such as ulcerative colitis. In the new study, published in the June 8 issue of Science, researchers at Cedars-Sinai’s Inflammatory Bowel and Immunobiology Research Institute identified and characterized the large community of fungi inhabiting the large intestine in a model of the disease.
Wengui Yu, MD, PhD, a research scientist and clinician specializing in stroke treatment and neurocritical care, has been named director of Cedars-Sinai Medical Center’s Neuroscience Critical Care Unit, one of the most advanced in the state. The recently expanded 24-bed unit, part of the Department of Neurology and Department of Neurosurgery, treats a high volume of patients with neurological disorders.
David L. Rimoin, MD, PhD, director of the Cedars-Sinai Medical Genetics Institute, a pioneer in research in skeletal disorders and abnormalities who played a pivotal role in developing mass screenings for Tay-Sachs and other heritable disorders, died early Sunday in Los Angeles. He was 75.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this “gold standard” method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
Ilana Cass, MD, vice-chair of the Department of Obstetrics and Gynecology at Cedars-Sinai and a prominent specialist in gynecologic cancers, is one of only 50 physicians internationally accepted to a program that prepares exceptional women faculty for senior leadership positions at academic health centers. She is the first candidate from Cedars-Sinai to be nominated and the first accepted to the year-long Hedwig van Ameringen Executive Leadership in Academic Medicine fellowship.
Cedars-Sinai has received the Accreditation Council for Graduate Medical Education’s first approval for an obstetric anesthesiology fellowship program. The year-long fellowship provides advanced experience and training in all aspects of obstetric anesthesiology including research, administration and clinical management of both normal and high-risk patients.
Cedars-Sinai experts are available to comment on a newly-released Centers for Disease Control recommendation that Baby Boomers be screened for Hepatitis C.
Nicole Soriano had headaches before but nothing like the one that struck in the middle of one summer night. A coincidence led nine days later to Cedars-Sinai Medical Center, where a rare type of migraine was diagnosed and treated – but any moment during that time could have been disastrous.
Cedars-Sinai Heart Institute is honoring Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine at Harvard Medical School, with The Eliot Corday, MD, International Prize in Heart Research. The Corday Prize has been established to recognize physicians and scientists conducting groundbreaking research that has, or very likely will, change the practice of heart medicine. Braunwald is the inaugural recipient of the annual prize.
Sandra Rome, RN, MN, AOCN, a clinical nurse specialist in hematology and oncology at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, has received the Distinguished Alumni Award from the UCLA School of Nursing.
Scientists have confirmed that mutations of a gene are responsible for some cases of a rare, inherited disease that causes progressive muscle degeneration and weakness: spinal muscular atrophy with lower extremity predominance, also known as SMA-LED.
Humberto Irigoyen’s jiu-jitsu partner had him in a choke hold when a jolt like electricity flashed through his body. “I’d never felt anything like that before,” says the former Marine . The next time the shock came – when he turned his head to breathe while swimming – it was so strong his whole body “just kind of stopped.” “That was one of my biggest scares,” recalls Irigoyen, a Los Angeles Police Department detective. . .
Cedars-Sinai Medical Center’s Stroke Program was recently spotlighted by the American Heart Association/American Stroke Association for earning the highest achievement in the association’s initiative to improve outcomes for patients suffering strokes: the Get With the Guidelines Gold Plus award.
Cedars-Sinai Medical Center has become the first West Coast site -- and one of only three nationwide -- to implant a device that stimulates the respiratory muscle in the chest and draws air into the lungs of patients suffering from amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease) under recently approved Food and Drug Administration guidelines.
Artist Len Steckler has photographed and painted the celebrated and glamorous, the brightest stars on the planet. In one well-known series of photos, he captured images of his friend, the poet and author Carl Sandburg, with Marilyn Monroe – eight months before her death. But Steckler, who is in his early 80s, says he only began to see – really see – after the 2005 loss of his left eye to skin cancer and a series of strokes in early 2011.
Robert H. Baloh, MD, PhD, director of Cedars-Sinai Medical Center’s Neuromuscular Division, has received the ALS Association Golden West Chapter Commitment to a Cure Award.
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson’s disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
If you are seeking an expert on prostate cancer Dr. Howard Sandler is available. To arrange interviews, or for more information, please contact Simi Singer at 310-423-7798.
Vice president for clinical innovation at Cedars-Sinai Medical Center available for interviews on the need for ‘living wills,’ other directives as National Healthcare Decisions Day approaches on April 16
If you’re seeking an outside expert to comment on an upcoming (embargoed) study suggesting a link between dental x-rays and brain tumors, Keith L. Black, M.D., Chairman of the Department of Neurosurgery at Cedars-Sinai Medical center is available. He hasn't had a dental x-ray in 20+ years.
In light of today's unified recommendation by nine specialty medical boards for less medical testing, Glenn D. Braunstein, MD, vice president for clinical innovation at Cedars-Sinai Medical Center is available for interviews. Dr. Braunstein says medical specialty boards are right to call for fewer tests at a time when medical providers are trying to simultaneously provide quality care and contain costs. “Our healthcare system is very fragmented, and this results in a lot of unnecessary testing,” he says.
Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute is the only cancer center in Los Angeles to receive a Commission on Cancer 2011 Outstanding Achievement Award for providing quality care and services to cancer patients.
For the second year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed the most adult heart transplants of any U.S. medical center, according to government statistics.
Patients diagnosed with aortic stenosis who are too sick for open-heart surgery have better survival rates and an improved quality of life after undergoing catheter-based heart valve replacement than if the patients had been treated with standard medical therapy, according to a study authored by a Cedars-Sinai Heart Institute physician based on results from a multicenter clinical trial.
Cedars-Sinai researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication’s April print edition.
Two physicians from the Cedars-Sinai Heart Institute will receive the American College of Cardiology’s highest honors for scientific research and clinical care during the organization’s upcoming annual scientific meeting in Chicago.
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson’s disease, dystonia and tremor, also may help patients who suffer from treatment-resistant obsessive-compulsive disorder or depression. The conference covers the principles of DBS and provides hands-on training.
Cedars-Sinai researchers have unlocked the mystery of how an inflammatory molecule is produced in the body, a discovery they say could lead to advances in the treatment of rheumatoid arthritis, Type 2 diabetes and numerous other chronic diseases that affect tens of millions of people.
Los Angeles Mayor Antonio Villaraigosa, presenting Keith L. Black, MD, with one of the city’s highest honors – the Hope of Los Angeles award – said the neurosurgeon’s innovative care and research efforts bring hope to patients throughout the region and the world.
During her 34-year career, Rita Shane, PharmD, has earned a reputation as a tireless advocate for patient safety – one who has transformed the way pharmacists perform their jobs. Now that work has brought Shane, director of pharmacy services at Cedars-Sinai Medical Center, the highest honor for health system pharmacists.
A Cedars-Sinai research scientist has been awarded two national grants totaling more than $2.5 million, including a prestigious Research Project Grant from the National Institutes of Health to study potential treatments for Alzheimer’s disease.
Every year, 7,000 babies are born at Cedars-Sinai Medical Center – many of them to Jewish parents who have questions about the role of Judaism in their new families. Now Cedars-Sinai is providing answers in a novel workshop for expectant couples seeking to navigate Judaism’s ancient traditions in their modern lives.
At the International Stroke Conference, Cedars-Sinai neurology researchers present findings on therapeutic cooling for stroke, damaging effects of normally beneficial blood component following ischemic stroke, and more.
Hundreds of health care professionals at the Cedars-Sinai Heart Institute will wear red on Friday, Feb. 3, to mark National Go Red for Women Day. The group will meet at 9 a.m. for a group photo to demonstrate support for increased research on heart disease, the No. 1 killer in the U.S. For the first time the annual gathering this year will include blood pressure checks and heart disease risk assessments.
Asma M. Moheet, MD, has been named director of Cedars-Sinai Medical Center’s Neurocritical Care Fellowship program, a two-year training program for doctors who have completed a neurology residency and wish to specialize in neurological intensive care. Moheet is one of three neurointensivists who oversee patient care in Cedars-Sinai’s highly sophisticated, 12-bed neuro ICU, which treats a high volume of patients suffering from a range of neurological and neurosurgical diagnoses.
Cedars-Sinai Medical Center’s annual Brainworks program introduces young people to the excitement and benefits of careers in science and medicine. This year’s event, occurring on Feb. 13 during Black History Month, will entertain and educate students from predominantly minority communities who attend Johnnie L. Cochran Jr. Middle School, James A. Forshay Learning Center, Lighthouse Church School, Greater New Jerusalem Missionary Baptist Church and an independent after-school program.
Robert H. Baloh, MD, PhD, an expert in genetic defects and molecular mechanisms causing neuromuscular and neurodegenerative diseases, has joined Cedars-Sinai Medical Center to advance the study of amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease), muscular dystrophies, spinal muscular atrophies and other poorly understood disorders that start in nerve cells and electrical signaling.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
The Commission on Cancer, a national consortium of organizations dedicated to improving survival rates and quality of life for cancer patients, has recognized Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute as one of nation’s foremost cancer programs.
Stephanie Weiss was facing open-brain surgery in June of this year. With 5 brain aneurysms – at least one of which was a wide-neck aneurysm – she was told there was no minimally invasive option for her. But when she went for a second opinion she learned about a new device – approved by the Food and Drug Administration just two months earlier – that made it possible to close even wide-neck aneurysms like hers.
The Accreditation Council for Graduate Medical Education has approved a neurology residency training program at Cedars-Sinai Medical Center. Recruitment of the first group of three residents is under way through the 2012 “match,” a process in which an independent organization pairs applicants with programs to meet the preferences of each.
The National Institutes of Health has awarded a four-year, $1.4 million grant to Cedars-Sinai’s Department of Neurology to study an unexpected recent discovery: After ischemic stroke – the type caused by a clogged artery but with no bleeding into the brain – a normal protein that plays a positive role in blood clotting escapes intact arteries and damages healthy brain cells.
It must have been nearly 15 years ago that James Babiak’s wife, Beverly, saw neurosurgeon Keith Black, MD, interviewed on the evening news and nonchalantly said, “Boy, if I ever need brain surgery, that’s the man I’m going to.” She’s fine. No surgery needed. But in the first week of February 2010, doctors detected a colloid cyst deep inside James’ brain, and when the neurologist asked the Lancaster couple if they had a preferred neurosurgeon, they did.
Among the most commonly used treatments for irritable bowel syndrome – which affects as many as 20 percent of the United States population – a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers, based on an analysis of 26 large-scale clinical trials.
Veronica Cappalonga, of Los Angeles, was diagnosed at age 6 with leukemia. She wanted to become a spokesperson for children with cancer, but six years ago, she developed a malignant brain tumor. Because of the tumor and aggressive treatment, Veronica has right-side weakness and difficulty speaking, but her family is working to help her achieve everything she can – and that’s more than some people expect. Now 28, Veronica will walk in the Nov. 6 Heroes of Hope Race for Brain Tumor Research – not only to help raise funds, but also to show that survivors can fight these diseases with dignity.
Patients with major depression do better by learning to create a more positive outlook about the future, rather than by focusing on negative thoughts about their past experiences, researchers at Cedars-Sinai say after developing a new treatment that helps patients do this.
Cedars-Sinai Medical Center in Los Angeles is seeking “Sleepwalkers” in all 50 states to be part of its seventh annual run for her® 5K Run and Friendship Walk on Sunday, Nov. 13, 2011. This event raises awareness about ovarian cancer and supports the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute.
Cedars-Sinai has combined efforts with the Translational Genomics Research Institute (TGen) in Arizona so researchers may offer joint clinical trials and collaborate to develop personalized therapies that could lead to more effective cancer treatments.
Edward M. Wolin, MD, co-director of the carcinoid and neuroendocrine tumor program at Samuel Oschin Cancer Center, is available today to discuss Pancreatic Neuroendocrine Cancer. He has one of the nation’s largest practices specializing in pancreatic neuroendocrine cancer. He did not treat nor see Jobs but can authoritatively discuss the disease and newly available treatments for patients fighting it.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right